<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">02907</article-id><article-id pub-id-type="doi">10.7554/eLife.02907</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-12539"><name><surname>Ji</surname><given-names>Xiaodan</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular and Cell Biology</named-content></addr-line>, <institution>Univeristy of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10844"><name><surname>Lu</surname><given-names>Huasong</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular and Cellular Biology</named-content></addr-line>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-2968"><name><surname>Zhou</surname><given-names>Qiang</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular and Cell Biology</named-content></addr-line>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-12714"><name><surname>Luo</surname><given-names>Kunxin</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular and Cell Biology</named-content></addr-line>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country><email>kluo@berkeley.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1082"><name><surname>Espinosa</surname><given-names>Joaquin M</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, University of Colorado</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>22</day><month>07</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e02907</elocation-id><supplementary-material><ext-link xlink:href="elife-02907-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>26</day><month>03</month><year>2014</year></date><date date-type="accepted"><day>18</day><month>07</month><year>2014</year></date></history><permissions><copyright-statement>Copyright Â© 2014, Ji et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Ji et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Transcriptional elongation by RNA polymerase (Pol) II is essential for gene expression during cell growth and differentiation. The positive transcription elongation factor b (P-TEFb) stimulates transcriptional elongation by phosphorylating Pol II and antagonizing negative elongation factors. A reservoir of P-TEFb is sequestered in the inactive 7SK snRNP where 7SK snRNA and the La-related protein LARP7 are required for the integrity of this complex. Here we show that P-TEFb activity is important for the epithelial-mesenchymal transition (EMT) and breast cancer progression. Decreased levels of LARP7 and 7SK snRNA redistribute P-TEFb to the transcriptionally active super elongation complex, resulting in P-TEFb activation and increased transcription of EMT transcription factors, including Slug, FOXC2, ZEB2 and Twist1, to promote breast cancer EMT, invasion and metastasis. Our data provide the first demonstration that the transcription elongation machinery plays a key role in promoting breast cancer progression by directly controlling the expression of upstream EMT regulators.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animals were handled according to the approved animal protocol (#R239) by the Institutional Animal Care and Use Committee (ACUC) of the University of California, Berkeley. All animal experiments were performed following the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.</p></fn></fn-group></back></article>